# Antoni Bayés‐Genís

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/antoni-bayes-genis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,175 |
| Field | Heart Failure Treatment and Management |
| h-index | 93 |
| i10-index | 659 |
| Last Known Institution | Centro de Investigación en Red en Enfermedades Cardiovasculares |
| OpenAlex ID | https://openalex.org/A5016593285 |
| ORCID iD | https://orcid.org/0000-0002-3044-197X |
| Works | 1,513 |

## Researcher papers

- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Empagliflozin after Acute Myocardial Infarction](https://scholariq.org/papers/empagliflozin-after-acute-myocardial-infarction/)
- [Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology](https://scholariq.org/papers/heart-failure-and-diabetes-metabolic-alterations-and-therapeutic-interventions-a/)
- [Colchicine Treatment for Recurrent Pericarditis](https://scholariq.org/papers/colchicine-treatment-for-recurrent-pericarditis/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)
- [Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure](https://scholariq.org/papers/prognostic-value-of-high-sensitivity-troponin-t-in-chronic-heart-failure/)
- [Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality](https://scholariq.org/papers/long-term-potassium-monitoring-and-dynamics-in-heart-failure-and-risk-of/)
- [Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure](https://scholariq.org/papers/meta-analysis-of-soluble-suppression-of-tumorigenicity-2-and-prognosis-in-acute/)
- [Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial](https://scholariq.org/papers/vericiguat-in-patients-with-chronic-heart-failure-and-reduced-ejection-fraction/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiac Fibrosis and Remodeling](https://scholariq.org/topics/cardiac-fibrosis-and-remodeling/)

## Researcher university

- [Centro de Investigación en Red en Enfermedades Cardiovasculares](https://scholariq.org/institutions/centro-de-investigacion-en-red-en-enfermedades-cardiovasculares/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.